[Clinical experiences with a new vasodilator: 3-(methylhydroxyethylamino)-2-hydroxypropyltheophylline nicotinate].
D000328:Adult; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use*; D013806:Theophylline / Q000627:therapeutic use*; D014652:Vascular Diseases / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D009539:Nicotinic Acids; D014665:Vasodilator Agents; D013806:Theophylline
Esperienze cliniche su un nuovo vasodilatatore: nicotinato di 3-(metil-ossietilamino) 2-ossipropilteofillina.